Nanoplasmas is a spin-off company of NCSR Demokritos, with expertise in micro-nanotechnology and surface engineering, preparing high-end consumables for health, food safety, agricultural and environmental applications. Its patented technology has been incorporated into microfluidic devices creating lab-on-chip diagnostics. Nanoplasmas has several other products in the pipeline based on its innovative plasma nanotexturing technology.

The company started as a team of researchers at NCSR Demokritos working on surface engineering and microfluidics for various applications and ended up as a spin-off collaborating with large companies and organizations inside and outside Greece.

In 2017, Nanoplasmas identified an opportunity in the water safety sector coming from new legislations for water quality (https://eur-lex.europa.eu/eli/dir/2020/2184/oj) and in particular in the detection of pathogens in water. So, Nanoplasmas focused on the water analysis market and more specifically, in the detection of Legionella, producing a lab-on-a-chip kit providing accurate results within 1-2 hours instead of several days if using the bacteria culture method.

At the same time, the COVID-19 crisis made Nanoplasmas identify new market gaps and work on two other products: 1. A diagnostic kit which can detect the presence of the SARS-CoV-2 on solid surfaces, air-conditioning and ventilation systems addressing a colossal billion market worldwide. 2. Nanoplasmas SARS-CoV-2 molecular diagnostic kit (CE-IVD certified) for human samples. This product is a portable molecular diagnostic kit that can accurately detect the SARS-CoV-2 virus in 20-60 minutes, facilitating rapid molecular analysis of potentially infected individuals. The diagnosis is made by detecting the genetic material of the virus, as it is done with the gold-standard RT-PCR detection method. The Nanoplasmas diagnostic kit is highly flexible and can be adapted to laboratory as well as to non-laboratory conditions.